vTv Therapeutics (VTVT) Interest Coverage Ratio (2014 - 2026)
vTv Therapeutics (VTVT) reported Interest Coverage Ratio of 1.12 for Q1 2026, up 102.23% on a YoY basis from 0.55 in Q1 2025, and up 100.01% sequentially from 7885.0 in Q4 2025.
vTv Therapeutics (VTVT) Interest Coverage Ratio (2014 - 2026) Analysis & Trends
vTv Therapeutics (VTVT) has 13 years of Interest Coverage Ratio data on file, last reported at 1.12 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio rose 102.23% year-over-year to 1.12; the trailing twelve-month figure through Mar 2026 stood at 0.15 (up 99.92% YoY), and the FY2025 full-year result was 0.65, up 7.89% from the prior year.
- Interest Coverage Ratio advanced to 1.12 in Q1 2026, from 7885.0 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 1.12 in Q1 2026 to a low of 7885.0 in Q4 2025.
- A 5-year average of 958.36 and a median of 26.11 in 2024 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio plunged 7300.17% in 2025 and surged 102.23% in 2026, its largest moves.
- Tracing VTVT's Interest Coverage Ratio over 5 years: stood at 1057.17 in 2022, then jumped by 36.39% to 672.43 in 2023, then plunged by 263.76% to 2446.0 in 2024, then plunged by 222.36% to 7885.0 in 2025, then surged by 100.01% to 1.12 in 2026.
- Business Quant data shows VTVT's Interest Coverage Ratio at 1.12 in Q1 2026, 7885.0 in Q4 2025, and 2139.8 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -0.38 |
| 10 | vTv Therapeutics | 19.21 Mn | 19.21 Mn | - | 1.12 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.12 |
| Dec 31, 2025 | -7,885.00 |
| Sep 30, 2025 | -2,139.80 |
| Mar 31, 2025 | -50.41 |
| Dec 31, 2024 | -2,446.00 |
| Sep 30, 2024 | -28.92 |
| Jun 30, 2024 | -26.11 |
| Mar 31, 2024 | -17.48 |
| Dec 31, 2023 | -672.43 |
| Sep 30, 2023 | -12.81 |
| Jun 30, 2023 | -17.09 |
| Dec 31, 2022 | -1,057.17 |
| Sep 30, 2022 | -9.02 |
| Jun 30, 2022 | -5.78 |
| Mar 31, 2022 | -8.51 |
| Dec 31, 2021 | -2,221.80 |
| Sep 30, 2021 | -1.80 |
| Jun 30, 2021 | -4.89 |
| Mar 31, 2021 | -15.56 |
| Dec 31, 2020 | 27.31 |